Member Info for unhooked

Classic sp action of a hated stock in the lead up to Full Year Results... which are tomorrow.

Also today: Berenberg raises Liontrust Asset Management to 'buy' (hold) - price target 410 (270) pence.

Yes, a "cluster buy" from 3 directors amounting to £4.1m, mostly from the Chair, but £350K's worth from the CEO and £180K's worth from the CFO. If that isn't a strong predictor of future upside, I don't know what is.

Here's me bottom fishing again, but surely this is a genuine case of delayed gratification. Risk/reward look too good to ignore down here.... in my view.

The below technical/chart analysis has proven to be wildly inaccurate. I was never a fan....

That this morning's sp remains 20% below any of these rejected offers, tells us that Mr Market has severe doubts anything meaningful will happen.

James Carthew, head of investment company research at QuotedData, said: “With the dividend cancelled, it is sounding as though SDCL Efficiency Income shareholders may have to wait a long while before they see any cash from the managed wind-down, as money freed up will be used to pay down debt in the first instance. The shares on a 48% discount may prove to be a bargain but, I am concerned that, if rushed, the wind down could be value destructive, so not a one-way bet.”

Seems "the shorts have it, the shorts have it"....

Share price unmoved. Resolution of the company's financing is all that matters now.

Last week I actually came back into this share - mopped up a small amount of cash for a total binary punt. No joy so far but keeps me in the game. I'd love to get something back from one of these hapless biotechs... !!

Another upgrade from Deutsche Bank, now 1250p. As so often, I've been top-slicing on the way up and now wish I hadn't. Still, mustn't complain, this has been a win, esp. with divis accrued.

Feel free to blame me.

I bought in a couple of days ago and am already 6% down.

Classic.

Company confirms its move to a NYSE listing and will not maintain a secondary listing at the LSE. Expect recent downward pressure on the share has been caused by, among other things, UK mandated funds selling out.

Interesting how the share price dropped 6% first thing this morning but ended up in the black at the close. I take that as a good sign. Could we be at or near the bottom with all the major selling maybe done?

Just catching up and I note that shares in sister company Trellus Health plc were suspended recently.

Who's next, VRCI or RENX? Place your bets...

Interesting the connection between Barclays and Saba. To the extent that there is informal collusion between the two, I'm afraid it's working. The price keeps dropping and I'm tempted to add, but, apart from anything else, the macro is so unappealing.

Very much agree that a buy-back would be helpful. The the lack of one is strange and undermining. Perhaps even a buy-back combined with a tender offer at a small premium for, say, 10% of the outstanding shares. That would demonstrate management's confidence that the share is currently undervalued and it also really reduces the share count fast. This is exactly what Strix plc, another of my holdings, did recently with a large amount of cash sitting on their balance sheet following the sale of an asset,. Much better than greedily splurging it all on vanity acquisitions.

Make that 54p. A steady decline of 1p every 2 or 3 days for what seems like ages - share was 68p just a few weeks ago. Half expecting an RNS revealing a major seller....

And a nasty broker downgrade, courtesy of Barclays, contributing to this morning's weakness.

Plus most domestic based investments are suffering today on election results day. Why oh why did I stay so loyal to UK plc?? Basket case.

Agitating for board changes at the NED level. Exciting times? My wallet doesn't think so.

And the threat to world trade arising from the middle east conflict.

And latterly news that the company may move its listing to the US market...

Complications, complications, was it ever thus?

Should've bailed a few weeks ago.